Not that my personal opinion matters, but I like the PR. Finally kicking things off in Mexico. It says Mexico already thinks our drug is a winner and we are doing the obligatory "testing" on a few Mexico patients. Market may see it that way as well(bid/ask on otcmarkets.com is up) Also, NP generally likes to follow up PRs with proactive videos. Now he may not, but if there is a little inside update he wants to share with us shareholders I'm all for it. Even if it can't be specific, a generalized statement like "the current data we've seen so far on the (mm or SC trials) is looking very promising..."